Collin is a PhD candidate in Biomedical AI at Mount Sinai, where he develops and applies machine learning methods for emerging single-cell and spatial biotechnologies, modeling cellular dynamics in Alzheimer's Disease and aging to discover novel therapeutic targets.

Beyond the lab, he is passionate about growing the biotech community. He co-founded Nucleate NYC, an accelerator for life science ventures, and Nucleate Policy, an initiative to educate and incubate biotech policy. He also serves as a co-founder and board member of OUTbio Greater New York to connect and support the LGBT+ biotech community.